These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

441 related items for PubMed ID: 31707357

  • 1. Adenosine deaminase 2 as a biomarker of macrophage activation syndrome in systemic juvenile idiopathic arthritis.
    Lee PY, Schulert GS, Canna SW, Huang Y, Sundel J, Li Y, Hoyt KJ, Blaustein RB, Wactor A, Do T, Halyabar O, Chang MH, Dedeoglu F, Case SM, Meidan E, Lo MS, Sundel RP, Richardson ET, Newburger JW, Hershfield MS, Son MB, Henderson LA, Nigrovic PA.
    Ann Rheum Dis; 2020 Feb; 79(2):225-231. PubMed ID: 31707357
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. IL-18 as a biomarker linking systemic juvenile idiopathic arthritis and macrophage activation syndrome.
    Yasin S, Fall N, Brown RA, Henderlight M, Canna SW, Girard-Guyonvarc'h C, Gabay C, Grom AA, Schulert GS.
    Rheumatology (Oxford); 2020 Feb 01; 59(2):361-366. PubMed ID: 31326996
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Differences and similarities of multisystem inflammatory syndrome in children, Kawasaki disease and macrophage activating syndrome due to systemic juvenile idiopathic arthritis: a comparative study.
    Otar Yener G, Paç Kısaarslan A, Ulu K, Atalay E, Haşlak F, Özdel S, Bozkaya Yücel B, Gezgin Yıldırım D, Çakmak F, Öztürk K, Çakan M, Balık Z, Hasbal Akkuş C, Yıldız M, Erat T, Çetin BŞ, Yılmaz M, Bağlan E, Laçinel Gürlevik S, Atasayan V, Karadağ ŞG, Adrovic A, Çağlayan Ş, Tanatar A, Demirkan FG, Coşkuner T, Akgün Ö, Kasap Cüceoğlu M, Kavrul Kayaalp G, Şahin S, Başaran Ö, Demir F, Barut K, Çiftel M, Gürses D, Baykan A, Özsürekçi Y, Karagöz T, Sönmez HE, Bilginer Y, Aktay Ayaz N, Aydoğ Ö, Yüksel S, Sözeri B, Kasapçopur Ö, Özen S.
    Rheumatol Int; 2022 May 01; 42(5):879-889. PubMed ID: 34491393
    [Abstract] [Full Text] [Related]

  • 8. Cytokines in systemic juvenile idiopathic arthritis and haemophagocytic lymphohistiocytosis: tipping the balance between interleukin-18 and interferon-γ.
    Put K, Avau A, Brisse E, Mitera T, Put S, Proost P, Bader-Meunier B, Westhovens R, Van den Eynde BJ, Orabona C, Fallarino F, De Somer L, Tousseyn T, Quartier P, Wouters C, Matthys P.
    Rheumatology (Oxford); 2015 Aug 01; 54(8):1507-17. PubMed ID: 25767156
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Clinical and laboratory features, treatment, and outcomes of macrophage activation syndrome in 80 children: a multi-center study in China.
    Zou LX, Zhu Y, Sun L, Ma HH, Yang SR, Zeng HS, Xiao JH, Yu HG, Guo L, Xu YP, Lu MP.
    World J Pediatr; 2020 Feb 01; 16(1):89-98. PubMed ID: 31612427
    [Abstract] [Full Text] [Related]

  • 11. A dysregulated interleukin-18-interferon-γ-CXCL9 axis impacts treatment response to canakinumab in systemic juvenile idiopathic arthritis.
    Hinze T, Kessel C, Hinze CH, Seibert J, Gram H, Foell D.
    Rheumatology (Oxford); 2021 Nov 03; 60(11):5165-5174. PubMed ID: 33576397
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Elevated circulating levels of interferon-γ and interferon-γ-induced chemokines characterise patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.
    Bracaglia C, de Graaf K, Pires Marafon D, Guilhot F, Ferlin W, Prencipe G, Caiello I, Davì S, Schulert G, Ravelli A, Grom AA, de Min C, De Benedetti F.
    Ann Rheum Dis; 2017 Jan 03; 76(1):166-172. PubMed ID: 27296321
    [Abstract] [Full Text] [Related]

  • 15. Comparison of serum cytokine profiles in macrophage activation syndrome complicating different background rheumatic diseases in children.
    Mizuta M, Shimizu M, Irabu H, Usami M, Inoue N, Nakagishi Y, Wada T, Yachie A.
    Rheumatology (Oxford); 2021 Jan 05; 60(1):231-238. PubMed ID: 32681176
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The frequency of macrophage activation syndrome and disease course in systemic juvenile idiopathic arthritis.
    Çakan M, Karadağ ŞG, Tanatar A, Ayaz NA.
    Mod Rheumatol; 2020 Sep 05; 30(5):900-904. PubMed ID: 31462146
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. An unusual presentation of purine nucleoside phosphorylase deficiency mimicking systemic juvenile idiopathic arthritis complicated by macrophage activation syndrome.
    Arduini A, Marasco E, Marucci G, Pardeo M, Insalaco A, Caiello I, Moneta GM, Prencipe G, De Benedetti F, Bracaglia C.
    Pediatr Rheumatol Online J; 2019 May 22; 17(1):25. PubMed ID: 31118063
    [Abstract] [Full Text] [Related]

  • 20. Identification of the best cutoff points and clinical signs specific for early recognition of macrophage activation syndrome in active systemic juvenile idiopathic arthritis.
    Kostik MM, Dubko MF, Masalova VV, Snegireva LS, Kornishina TL, Chikova IA, Likhacheva TS, Isupova EA, Glebova NI, Kuchinskaya EM, Balbotkina EV, Buchinskaya NV, Kalashnikova OV, Chasnyk VG.
    Semin Arthritis Rheum; 2015 Feb 22; 44(4):417-22. PubMed ID: 25300700
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.